V0111

V0111 is a topical cream developed by Pierre Fabre Medicament. It was investigated in a completed phase 3 clinical trial for the treatment of *cracked heels with fissures* in diabetic patients with polyneuropathy. The active pharmaceutical ingredient and mechanism of action for V0111 cream have not been publicly disclosed in available clinical or chemical registries. The cream is topical, and its clinical development was specifically in patients with diabetes who have neuropathy and deep heel fissures. No information is available to indicate that V0111 is an antiviral, antibiotic, or other drug currently in wide pharmaceutical use. No chemical information (e.g., structure, known class) is available in public chemical or drug databases as of September 2025[4].

Brand names

V0111V-0111V 0111

Other names

V0111V-0111V 0111